Mod­er­na halts African fa­cil­i­ty build as Covid-19 vac­cine de­mand plum­mets

Mod­er­na’s man­u­fac­tur­ing fu­ture in Africa is less clear af­ter the com­pa­ny held back plans to build an mR­NA vac­cine pro­duc­tion site in Kenya.

“Mod­er­na has not re­ceived any vac­cine or­ders for Africa since 2022 and has faced the can­cel­la­tion of pre­vi­ous or­ders, re­sult­ing in more than $1 bil­lion in loss­es and write-downs,” a spokesper­son told End­points News. With the con­struc­tion pause, the com­pa­ny will re­view what fu­ture de­mand for mR­NA vac­cines will be like in Africa, the spokesper­son added.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER